Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia
- 15 October 2008
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 102 (8), 1040-1045
- https://doi.org/10.1016/j.amjcard.2008.05.056
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart DiseaseThe American Journal of Cardiology, 2008
- Omega-3 fatty acids and cardiovascular disease: A case for omega-3 index as a new risk factorPharmacological Research, 2007
- Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study)The American Journal of Cardiology, 2007
- Non–High-Density Lipoprotein and Very-Low-Density Lipoprotein Cholesterol and Their Risk Predictive Values in Coronary Heart DiseaseThe American Journal of Cardiology, 2006
- Dietary Omega-3 Fatty Acid Intake and Cardiovascular RiskThe American Journal of Cardiology, 2006
- Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) IIAmerican Heart Journal, 2006
- Secondary Prevention of Coronary Artery Disease with Omega-3 Fatty AcidsThe American Journal of Cardiology, 2006
- Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group RecommendationsThe American Journal of Cardiology, 2005
- Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)The American Journal of Cardiology, 2005
- Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statinThe American Journal of Cardiology, 2005